IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 4 September 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00658-07v1
75/11/5509    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bai, G.
Right arrow Articles by McDonough, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bai, G.
Right arrow Articles by McDonough, K. A.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00658-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Mycobacterium bovis BCG CRP-like protein (CRPBCG) is a functional DNA binding protein in vitro and in vivo, but its activity differs from that of its M. tuberculosis ortholog Rv3676 (CRPMt)

Guangchun Bai, Michaela A. Gazdik, Damen D. Schaak, and Kathleen A. McDonough*

Wadsworth Center, New York State Department of Health, and Department of Biomedical Sciences, School of Public Health, University at Albany, PO Box 22002, Albany, NY 12201-2002

* To whom correspondence should be addressed. Email: kathleen.mcdonough{at}wadsworth.org.


   Abstract

Mycobacterium tuberculosis Rv3676 encodes a CRP-like protein (CRPMt) that has been implicated in global gene regulation, and may play an important role during TB infection. The CRPMt ortholog in M. bovis BCG, CRPBCG, is dysfunctional in an E. coli CRP competition assay, and has been proposed as a potential source of M. bovis BCG's attenuation. We compared CRPBCG and CRPMt in vitro and in vivo, in M. bovis BCG and M. tuberculosis, to evaluate CRPBCG's potential function in a mycobacterial system. Both proteins formed dimers in mycobacterial lysates, bound to the same target DNA sequences and were similarly affected by the presence of cAMP in DNA binding assays. However, CRPMt and CRPBCG differed in their relative affinities for specific DNA target sequences, and susceptibility to protease digestion. Surprisingly, CRPBCG DNA binding activity was stronger than that of CRPMt both in vitro and in vivo, as measured by electrophoretic mobility shift and chromatin immunoprecipitation assays. Nutrient starvation-associated regulation of several CRPMt regulon members also differed between M. bovis BCG and M. tuberculosis. We conclude that CRPBCG is a functional cAMP-responsive DNA binding protein, with an in vivo DNA binding profile in M. bovis BCG similar to that of CRPMt in M. tuberculosis. However, biologically significant functional differences may exist between CRPBCG and CRPMt, with respect to gene regulation, and this issue warrants further study.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.